13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 42 holding rows worth $450,012,000.
- Accession
- 0001144204-16-119420
- Filer
- CIK 1633313
- Filed
- 2016-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 48 entries on the cover page, a total value of $450,012,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $450,012,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TESARO INC | 881569107 | COM | 514,000 | $43,202,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 4,338,557 | $35,142,000 | thousands by filing date | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 1,124,666 | $33,942,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 432,972 | $33,685,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 445,339 | $32,755,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,412,190 | $26,930,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 509,330 | $23,149,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 721,663 | $21,109,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,698,665 | $20,195,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 8,556,957 | $19,852,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 279,700 | $16,866,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 963,646 | $15,987,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 3,099,838 | $12,554,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 613,300 | $11,346,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 329,500 | $10,696,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 1,655,274 | $9,270,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 1,290,000 | $9,211,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 108,500 | $9,051,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 557,003 | $9,051,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 709,579 | $7,940,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,214,833 | $6,633,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC COM | 14740B101 | Stock | 5,744,723 | $5,418,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 503,900 | $4,782,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 621,873 | $4,652,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 918,556 | $4,620,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 1,326,636 | $3,569,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 624,600 | $2,603,000 | thousands by filing date | call |
| INNOCOLL HLDGS PLC | G4783X105 | SHS | 468,148 | $2,579,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 228,697 | $2,054,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,332,000 | $2,006,000 | thousands by filing date | put |
| ONCOBIOLOGICS INC | 68235M105 | COM | 466,667 | $1,587,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HLDGS IN | 71426VAK4 | DBCV 4.250 4/0 | 7,000,000 | $1,487,000 | thousands by filing date | principal |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 260,982 | $1,448,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 42,671 | $1,135,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 70,000 | $1,120,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 74,800 | $1,067,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 255,000 | $574,000 | thousands by filing date | |
| NANTKWEST INC | 63016Q102 | COM | 72,412 | $450,000 | thousands by filing date | |
| ONCOBIOLOG-CW17A | 68235M113 | EQUITY WRT | 233,333 | $107,000 | thousands by filing date | |
| ONCOBIOLOGICS INC | 68235M121 | *W EXP 05/18/201 | 233,333 | $105,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 453,900 | $64,000 | thousands by filing date | call |
| ISHARES TR | 464287955 | PUT | 50,000 | $19,000 | thousands by filing date | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-16-119420 | this filing | 2016-08-15 | acceptance time not in the bulk data set |